Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity.
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity.
复制标题
DOI:
10.1038/s41467-023-42205-6
复制
发表时间:
2023-11-15
影响因子:
16.6
通讯作者:
Baillie, J. Kenneth
中科院分区:
文献类型:
--
作者:
Swets, Maaike C.;Kerr, Steven;Scott-Brown, James;Brown, Adam B.;Gupta, Rishi;Millar, Jonathan E.;Spata, Enti;Mccurrach, Fiona;Bretherick, Andrew D.;Docherty, Annemarie;Harrison, David;Rowan, Kathy;Young, Neil;Groeneveld, Geert H.;Dunning, Jake;Nguyen-Van-Tam, Jonathan S.;Openshaw, Peter;Horby, Peter W.;Harrison, Ewen;Staplin, Natalie;Semple, Malcolm G.;Lone, Nazir;Baillie, J. Kenneth
Choosing optimal outcome measures maximizes statistical power, accelerates discovery and improves reliability in early-phase trials. We devised and evaluated a modification to a pragmatic measure of oxygenation function, the ratio. Because of the ceiling effect in oxyhaemoglobin saturation, ratio ceases to reflect pulmonary oxygenation function at high values. We found that the correlation of with the reference standard (/ ratio) improves substantially when excluding and refer to this measure as . Using observational data from 39,765 hospitalised COVID-19 patients, we demonstrate that is predictive of mortality, and compare the sample sizes required for trials using four different outcome measures. We show that a significant difference in outcome could be detected with the smallest sample size using . We demonstrate that is an effective intermediate outcome measure in COVID-19. It is a non-invasive measurement, representative of disease severity and provides greater statistical power. There is a need for an accurate measure of pulmonary oxygenation function that can be used as an intermediate endpoint in pragmatic clinical trials, to increase statistical power and efficiency. Here, the authors show that the S/F94, a modification of the S/F ratio, is a simple, meaningful and effective intermediate outcome measure.
登录
查看更多内容
影响因子:
--
作者:
Carvalho, Eduardo Butturini de;Leite, Thiago Ravache Sobreira;Sacramento, Raquel Ferreira de Magalhaes;Nascimento, Paulo Roberto Loureiro do;Samary, Cynthia Dos Santos;Rocco, Patricia Rieken Macedo;Silva, Pedro Leme
通讯作者:
Silva, Pedro Leme
影响因子:
8.8
作者:
Brown, Samuel M.;Duggal, Abhijit;Brower, Roy G.
通讯作者:
Brower, Roy G.
DOI:
10.1016/s0140-6736(20)32008-0
发表时间:
2020-10-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
Barbaro RP;MacLaren G;Boonstra PS;Iwashyna TJ;Slutsky AS;Fan E;Bartlett RH;Tonna JE;Hyslop R;Fanning JJ;Rycus PT;Hyer SJ;Anders MM;Agerstrand CL;Hryniewicz K;Diaz R;Lorusso R;Combes A;Brodie D;Extracorporeal Life Support Organization
通讯作者:
Extracorporeal Life Support Organization
DOI:
10.1016/s0140-6736(22)01109-6
发表时间:
2022-07-30
期刊:
Lancet (London, England)
影响因子:
--
作者:
通讯作者:
--
影响因子:
9.6
作者:
Brown, Samuel M.;Grissom, Colin K.;Brower, Roy G.
通讯作者:
Brower, Roy G.